Morgan Stanley’s Synthorx, Inc. Common Stock THOR Stock Holding History

Morgan Stanley’s Portfolio THOR Stock Details THOR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-163,203	Closed	-$11.4M	–	6915
2019 Q4	$11.4M	Buy	163,203 +56,603	+53%	+$1.62M	﹤0.01%	2281
2019 Q3	$1.73M	Sell	106,600 -16,512	-13%	-$276K	﹤0.01%	3918
2019 Q2	$1.66M	Buy	123,112 +121,804	+9,312%	+$1.95M	﹤0.01%	3917
2019 Q1	$26K	Buy	1,308 +1,210	+1,235%	+$20.8K	﹤0.01%	5934
2018 Q4	$2K	Buy	+98	New	+$1.42K	﹤0.01%	6462

Morgan Stanley's THOR Position: Q1 2020 in Review

Morgan Stanley sold out of Synthorx, Inc. Common Stock (THOR) in Q1 2020, closing a stake of 163,203 shares — an estimated $11.4M sold.

Morgan Stanley first reported a position in THOR in Q4 2018 and held it in 5 quarters. The position peaked at $11.4M in Q4 2019. 0 funds tracked by Wall St. Rank hold THOR as of Q1 2020.

Morgan Stanley reported no remaining Synthorx, Inc. Common Stock position as of Q1 2020 after selling out during the quarter.
Morgan Stanley sold 163,203 Synthorx, Inc. Common Stock shares in Q1 2020, an estimated $11.4M.
Morgan Stanley first reported a position in Synthorx, Inc. Common Stock in Q4 2018 and held it in 5 quarters.
Morgan Stanley's Synthorx, Inc. Common Stock position peaked at $11.4M in Q4 2019.
0 funds tracked by Wall St. Rank held Synthorx, Inc. Common Stock as of Q1 2020.

Based on Morgan Stanley's 13F filing for Q1 2020, filed 15 May 2020.